Andra AP-fonden’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $28.4M | Buy |
57,814
+53,990
| +1,412% | +$29.3M | 0.34% | 54 |
|
|
2025
Q4 | $2.22M | Sell |
3,824
-2,974
| -44% | -$1.68M | 0.03% | 356 |
|
|
2025
Q3 | $3.3M | Sell |
6,798
-20,600
| -75% | -$9.59M | 0.04% | 294 |
|
|
2025
Q2 | $11.1M | Sell |
27,398
-2,600
| -9% | -$1.09M | 0.15% | 199 |
|
|
2025
Q1 | $14.9M | Sell |
29,998
-1,000
| -3% | -$542K | 0.24% | 149 |
|
|
2024
Q4 | $16.1M | Sell |
30,998
-1,300
| -4% | -$715K | 0.26% | 151 |
|
|
2024
Q3 | $20M | Sell |
32,298
-6,100
| -16% | -$3.61M | 0.29% | 112 |
|
|
2024
Q2 | $21.2M | Buy |
38,398
+9,200
| +32% | +$5.27M | 0.36% | 91 |
|
|
2024
Q1 | $17M | Buy |
+29,198
| New | +$16.4M | 0.3% | 101 |
|
|
2023
Q3 | – | Sell |
-14,998
| Closed | -$7.83M | – | 540 |
|
|
2023
Q2 | $7.83M | Sell |
14,998
-700
| -4% | -$378K | 0.2% | 202 |
|
|
2023
Q1 | $9.05M | Buy |
15,698
+2,898
| +23% | +$1.63M | 0.24% | 149 |
|
|
2022
Q4 | $7.05M | Buy |
12,800
+200
| +2% | +$106K | 0.21% | 178 |
|
|
2022
Q3 | $6.39M | Buy |
12,600
+900
| +8% | +$504K | 0.21% | 202 |
|
|
2022
Q2 | $6.36M | Buy |
+11,700
| New | +$6.44M | 0.18% | 237 |
|
|
2021
Q4 | $19.1M | Buy |
28,600
+2,300
| +9% | +$1.44M | 0.39% | 22 |
|
|
2021
Q3 | $15M | Sell |
26,300
-3,200
| -11% | -$1.76M | 0.31% | 44 |
|
|
2021
Q2 | $14.9M | Buy |
29,500
+900
| +3% | +$425K | 0.3% | 46 |
|
|
2021
Q1 | $13.1M | Sell |
28,600
-1,100
| -4% | -$525K | 0.29% | 50 |
|
|
2020
Q4 | $13.8M | Buy |
29,700
+2,700
| +10% | +$1.27M | 0.31% | 31 |
|
|
2020
Q3 | $11.9M | Buy |
27,000
+2,900
| +12% | +$1.2M | 0.32% | 25 |
|
|
2020
Q2 | $8.73M | Buy |
24,100
+4,200
| +21% | +$1.41M | 0.25% | 51 |
|
|
2020
Q1 | $5.64M | Sell |
19,900
-400
| -2% | -$126K | 0.21% | 118 |
|
|
2019
Q4 | $6.59M | Sell |
20,300
-2,000
| -9% | -$606K | 0.19% | 178 |
|
|
2019
Q3 | $6.5M | Sell |
22,300
-4,500
| -17% | -$1.29M | 0.19% | 181 |
|
|
2019
Q2 | $7.87M | Buy |
26,800
+1,900
| +8% | +$523K | 0.23% | 74 |
|
|
2019
Q1 | $6.82M | Buy |
+24,900
| New | +$6.2M | 0.2% | 161 |
|
|
2018
Q3 | $4.25M | Buy |
17,400
+3,100
| +22% | +$713K | 0.11% | 464 |
|
|
2018
Q2 | $2.96M | Sell |
14,300
-5,900
| -29% | -$1.25M | 0.08% | 551 |
|
|
2018
Q1 | $4.17M | Sell |
20,200
-14,800
| -42% | -$3.11M | 0.11% | 493 |
|
|
2017
Q4 | $6.65M | Sell |
35,000
-600
| -2% | -$115K | 0.15% | 180 |
|
|
2017
Q3 | $6.74M | Buy |
35,600
+1,500
| +4% | +$272K | 0.16% | 164 |
|
|
2017
Q2 | $5.95M | Sell |
34,100
-100
| -0.3% | -$16.8K | 0.15% | 185 |
|
|
2017
Q1 | $5.25K | Sell |
34,200
-6,300
| -16% | -$963K | 0.12% | 220 |
|
|
2016
Q4 | $5.71M | Sell |
40,500
-13,100
| -24% | -$1.93M | 0.16% | 184 |
|
|
2016
Q3 | $8.53M | Buy |
53,600
+1,500
| +3% | +$231K | 0.23% | 129 |
|
|
2016
Q2 | $7.7M | Buy |
52,100
+1,700
| +3% | +$251K | 0.2% | 138 |
|
|
2016
Q1 | $7.14M | Buy |
50,400
+4,000
| +9% | +$536K | 0.19% | 142 |
|
|
2015
Q4 | $6.58M | Buy |
46,400
+6,300
| +16% | +$840K | 0.19% | 136 |
|
|
2015
Q3 | $4.9M | Buy |
40,100
+25,500
| +175% | +$3.32M | 0.14% | 200 |
|
|
2015
Q2 | $1.89M | Buy |
14,600
+1,400
| +11% | +$183K | 0.05% | 482 |
|
|
2015
Q1 | $1.77M | Buy |
13,200
+6,300
| +91% | +$812K | 0.05% | 486 |
|
|
2014
Q4 | $865K | Buy |
6,900
+4,900
| +245% | +$596K | 0.02% | 540 |
|
|
2014
Q3 | $243K | Sell |
2,000
-26,000
| -93% | -$3.16M | 0.01% | 559 |
|
|
2014
Q2 | $3.3M | Sell |
28,000
-77,700
| -74% | -$9.14M | 0.07% | 377 |
|
|
2014
Q1 | $12.7M | Buy |
105,700
+2,600
| +3% | +$309K | 0.29% | 89 |
|
|
2013
Q4 | $11.5M | Sell |
103,100
-25,400
| -20% | -$2.53M | 0.27% | 92 |
|
|
2013
Q3 | $11.8M | Sell |
128,500
-31,000
| -19% | -$2.8M | 0.3% | 77 |
|
|
2013
Q2 | $13.5M | Buy |
+159,500
| New | +$13.3M | 0.35% | 60 |
|
Other funds holding TMO
VCM
Andra AP-fonden's TMO Position: Q1 2026 in Review
Andra AP-fonden increased its Thermo Fisher Scientific (TMO) stake by 1,412% in Q1 2026, buying an estimated $29.3M and bringing the position to 57,814 shares worth $28.4M. The position accounts for 0.34% of the portfolio, ranked #54.
Andra AP-fonden first reported a position in TMO in Q2 2013 and has held it in 48 quarters since. 2,589 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Andra AP-fonden held 57,814 shares of Thermo Fisher Scientific worth $28.4M as of Q1 2026.
- Andra AP-fonden bought 53,990 Thermo Fisher Scientific shares in Q1 2026, an estimated $29.3M.
- Thermo Fisher Scientific made up 0.34% of Andra AP-fonden's portfolio in Q1 2026, its #54 holding.
- Andra AP-fonden first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 48 quarters since.
- 2,589 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Andra AP-fonden's 13F filing for Q1 2026, filed 8 May 2026.